Related Experiment Video
Updated: Jun 18, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
What anesthesiologists should know about B-type natriuretic peptide
M Noveanu1, S Hartwiger, C Mueller
1Department of Internal Medicine, University Hospital, Basel, Switzerland.
Minerva Anestesiologica
|November 27, 2009
Summary
Natriuretic peptides (NPs), like BNP and NT-proBNP, are vital for diagnosing and managing heart failure (HF). Their measurement aids in emergency care and preoperative risk assessment, particularly for anesthesiologists.
Area of Science:
- Cardiology
- Clinical Biochemistry
- Anesthesiology
Background:
- Natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro BNP (NT-proBNP), are established biomarkers for cardiac stress.
- Their measurement is integral to current cardiovascular guidelines for heart failure (HF) diagnosis and management.
- NPs are increasingly recognized for their utility in critical care and perioperative settings.
Purpose of the Study:
- To review the clinical applications of natriuretic peptides.
- To highlight the relevance of NP measurement for anesthesiologists.
- To focus on NP use in acute dyspnea, Intensive Care Unit (ICU) patient management, and preoperative risk assessment.
Main Methods:
- Literature review of natriuretic peptide applications.
- Synthesis of evidence regarding NP utility in cardiovascular disease and critical care.
- Focus on practical implications for anesthesiology.
Main Results:
- NP measurement significantly improves the diagnosis and management of heart failure.
- NPs are valuable tools for predicting outcomes in patients with acute dyspnea.
- Applications extend to ICU patient care and preoperative risk stratification.
Conclusions:
- Natriuretic peptides are essential biomarkers in modern clinical practice.
- Their role in managing heart failure and assessing perioperative risk is well-established.
- Anesthesiologists can leverage NP measurements for enhanced patient management.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:13Local Anesthetics: Pharmacokinetics
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...